Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Table 1 Baseline characteristics of the patients in the four cohorts, n (%)
| Characteristics | Group I (n = 1029) | Group II (n = 157) | Group III (n = 154) | Group IV (n = 210) | P value |
| Age > 60 years | 323 (31.4) | 65 (41.4) | 46 (29.9) | 90 (42.9) | 0.001 |
| Male | 897 (87.2) | 145 (92.4) | 116 (75.3) | 167 (79.5) | < 0.001 |
| BMI > 24 kg/m2 | 513 (49.9) | 74 (47.1) | 60 (39.0) | 82 (39.0) | 0.005 |
| Hypertension | 251 (24.4) | 38 (24.2) | 25 (16.2) | 44 (21.0) | 0.127 |
| Diabetes | 126 (12.2) | 23 (14.6) | 26 (16.9) | 32 (15.2) | 0.305 |
| Alcohol consumption | 318 (30.9) | 54 (34.4) | 33 (21.4) | 62 (29.5) | 0.065 |
| ASA score >2 | 135 (13.1) | 25 (15.9) | 24 (15.6) | 32 (15.2) | 0.629 |
| HBV (+) | 827 (80.4) | 122 (77.7) | 136 (88.3) | 184 (87.6) | 0.006 |
| Cirrhosis | 610 (59.3) | 103 (65.6) | 109 (70.8) | 169 (80.5) | < 0.001 |
| Portal hypertension | 137 (13.3) | 24 (15.3) | 32 (20.8) | 81 (38.6) | < 0.001 |
| Child-Pugh grade A | 1029 (100.0) | 157 (100.0) | 150 (97.4) | 201 (95.7) | < 0.001 |
| Total bilirubin > 17.1 μmol/L | 293 (28.5) | 27 (17.2) | 56 (36.4) | 54 (25.7) | 0.002 |
| Preoperative ALT level > 40 U/L | 221 (21.5) | 47 (29.9) | 43 (27.9) | 89 (42.4) | < 0.001 |
| Preoperative AST level > 40 U/L | 155 (15.1) | 35 (22.3) | 51 (33.1) | 107 (51.0) | < 0.001 |
| Preoperative AFP level > 400 μg/L | 256 (24.9) | 41 (26.1) | 63 (40.9) | 69 (32.9) | < 0.001 |
| Largest tumor diameter > 5 cm | 398 (38.7) | 76 (48.4) | 92 (59.7) | 127 (60.5) | < 0.001 |
| Multiple tumors | 122 (11.9) | 20 (12.7) | 26 (16.9) | 34 (16.2) | 0.162 |
| Microvascular invasion | 394 (38.3) | 77 (49.0) | 78 (50.6) | 103 (49.0) | < 0.001 |
| Macrovascular invasion | 34 (3.3) | 5 (3.2) | 15 (9.7) | 18 (8.6) | < 0.001 |
| Satellites | 86 (8.4) | 14 (8.9) | 24 (15.6) | 32 (15.2) | 0.002 |
| Poor tumor differentiation | 486 (47.2) | 86 (54.8) | 89 (57.8) | 126 (60.0) | 0.001 |
| Incomplete tumor encapsulation | 739 (71.8) | 126 (80.3) | 137 (89.0) | 171 (81.4) | < 0.001 |
| BCLC stage | < 0.001 | ||||
| BCLC A stage | 863 (83.9) | 117 (74.5) | 107 (69.5) | 139 (66.2) | |
| BCLC B stage | 68 (6.6) | 14 (8.9) | 14 (9.1) | 18 (8.6) | |
| BCLC C stage | 98 (9.5) | 26 (16.6) | 33 (21.4) | 53 (25.2) | |
| Operative variables | |||||
| Operation time | 120 (100-155) | 135 (102-166) | 145 (110-175) | 140 (105-175) | < 0.001 |
| Intraoperative blood loss > 400 mL | 94 (9.1) | 24 (15.3) | 30 (19.5) | 45 (21.4) | < 0.001 |
| Intraoperative blood transfusion | 27 (2.6) | 6 (3.8) | 10 (6.5) | 22 (10.5) | < 0.001 |
| Major liver resection | 132 (12.8) | 29 (18.5) | 39 (25.3) | 53 (25.2) | < 0.001 |
| Non-anatomical liver resection | 892 (86.7) | 131 (83.4) | 133 (86.4) | 178 (84.8) | 0.673 |
| Resection margin < 1 cm | 673 (65.4) | 117 (74.5) | 110 (71.4) | 164 (78.1) | 0.001 |
- Citation: Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL, Zhao YF, Wang K. Comprehensive prognostic value of prealbumin and albumin in hepatocellular carcinoma resection: Insights from a Chinese multicenter cohort. World J Clin Oncol 2026; 17(11): 122944
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/122944.htm
- DOI: https://dx.doi.org/10.5306/wjco.122944